Estimates of human immunodeficiency virus incidence among female sex workers in north central Nigeria: Implications for HIV clinical trials

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 105, Issue 11, 2011, Pages 655-660

  Forbi, Joseph C ^a   Entonu, Peter E ^a   Mwangi, Lulu O ^b   Agwale, Simon M ^a  

^a Clinical Virology Department   (Nigeria)

^b ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION   (United States)

Author keywords

Estimation; FSWs; HIV; Incidence; Nigeria

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; ENZYME IMMUNOASSAY; FEMALE; FEMALE SEX WORKER; FEMALE WORKER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; PROSTITUTION; SEROPREVALENCE; SEXUAL BEHAVIOR; SYPHILIS; UNSAFE SEX; VIRUS IDENTIFICATION;

ADOLESCENT; ADULT; ALGORITHMS; ANTI-INFECTIVE AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; NIGERIA; SEX WORKERS; SYPHILIS; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80054056422     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2011.08.001     Document Type: Article

References (30)

1. UNAIDS. AIDS epidemic update: December 2007. [accessed 17 November 2009]. http://data.unaids.org/pub/EPISlides/2007/2007_epiupdate_en.pdf.
2. Federal Ministry of Health Nigeria. The 2005 national HIV seroprevalence sentinel survey among pregnant women attending antenatal clinics in Nigeria: summary position paper. Abuja: FMOH; 2006.
3. Kersh E.N., Luo W., Adams D.R., Mitchell J., Garcia-Lerma J.G., Heneine W., et al. No evidence of occult SHIV infection as demonstrated by CD8+ cell depletion after chemoprophylaxis-induced protection from mucosal infection in rhesus macaques. AIDS Res Hum Retroviruses 2008, 24:543-546.
4. Johnston M.I., Fauci A.S. An HIV vaccine--challenges and prospects. N Engl J Med 2008, 359:888-890.
5. Fauci A.S., Johnston M.I., Dieffenbach C.W., Burton D.R., Hammer S.M., Hoxie J.A., et al. HIV vaccine research: the way forward. Science 2008, 321:530-532.
6. Rerks-Ngarm S., Pitisuttithum P., Nitayaphan S., Kaewkungwal J., Chiu J., Paris R., et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 Infection in Thailand. N Engl J Med 2009, 361:2209-2220.
7. Centers for Disease Control. Update: barrier protection against HIV infection and other sexually transmitted diseases. MMWR 1993, 42:589-97.
8. Stone A.B., Hitchcock P.J. Vaginal microbicides for preventing the sexual transmission of HIV. AIDS 1994, 8:S285-S293.
9. Elias C.J., Coggins C. Female controlled methods to prevent sexual transmission of HIV. AIDS 1996, 10:S43-S51.
10. Wilson D.P., Coplan P.M., Wainberg M.A., Blower S.M. The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics. Proc Natl Acad Sci USA 2008, 105:9835-9840.
11. The International Working Group for Vaginal Microbicides. Recommendations for the development of vaginal microbicides. AIDS 1996, 10:S1-6.
12. Parekh B.S., Kennedy M.S., Dobbs T., Pau C.P., Byers R., Green T., et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002, 18:295-307.
13. Parekh B.S., Hanson D.L., Hargrove J., Branson B., Green T., Dobbs T., et al. Determination of mean recency period for estimation of HIV Type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes. AIDS Res Hum Retroviruses 2011, 27:265-273.
14. Hargrove J.W., Humphrey J.H., Mutasa K., Parekh B.S., McDougal J.S., Ntozini R., et al. Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS 2008, 22:511-518.
15. McWalter T.A., Welte A. Relating recent infection prevalence to incidence with a sub-population of assay non-progressors. J Math Biol 2010, 60:687-710.
16. Agwale SM, Zeh C, Robbins KE, Odama L, Saekhou A, Edubio A et al. Molecular surveillance of HIV-1 field strains in Nigeria in preparation for vaccine trials. Vaccine 2002, 20: 2131-9.
17. Ajoge H.O., Gordon M.L., de Oliveira T., Green T.N., Ibrahim S., Shittu O.S., et al. Genetic characteristics, coreceptor usage potential and evolution of Nigerian HIV-1 subtype G and CRF02_AG isolates. PLoS One 2011, 6:e17865.
18. Hargrove J.W. BED estimates of HIV incidence must be adjusted. AIDS 2009, 23:2061-2062.
19. Priddy F.H., Wakasiaka S., Hoang T.D., Smith D.J., Farah B., Del Rio C., et al. Anal sex, vaginal practices and HIV incidence in female sex workers in urban Kenya: Implications for development of intravaginal HIV prevention methods. AIDS Res Hum Retroviruses Forthcoming 2011, 10.1089/aid.2010.0362.
20. Gupta S.B., Murphy G., Koenig E., Adon C., Beyrer C., Celentano D., et al. Comparison of methods to detect recent HIV type 1 infection in cross-sectionally collected specimens from a cohort of female sex workers in the Dominican Republic. AIDS Res Hum Retroviruses 2007, 23:1475-1480.
21. Couture M.C., Sansothy N., Sapphon V., Phal S., Sichan K., Stein E., et al. Young women engaged in sex work in Phnom Penh, Cambodia, have high incidence of HIV and sexually transmitted infections, and amphetamine-type stimulant use: new challenges to HIV prevention and risk. Sex Transm Dis 2011, 38:33-39.
22. Xu J., Wang H., Jiang Y., Ding G., Jia M., Wang G., et al. Application of the BED capture enzyme immunoassay for HIV incidence estimation among female sex workers in Kaiyuan City, China, 2006-2007. Int J Infect Dis 2010, 14:e608-e612.
23. Albert A.E., Warner D.L., Hatcher R.A., Trussell J., Bennett C. Condom use among female commercial sex workers in Nevada's legal brothels. Am J Public Health 1995, 85:1514-1520.
24. Karita E., Price M., Hunter E., Chomba E., Allen S., Fei L., et al. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS 2007, 21:403-408.
25. Methodological challenges in HIV prevention trials 2008, Institute of Medicine, National Academy Press, Washington. S. Lagakos, A. Gable (Eds.).
26. Dada A.J., Oyewole F., Onofowokan R., Nasidi A., Harris B., Levin A. Demographic characteristics of retroviral infections (HIV-1, HIV-2, and HTLV-I) among female professional sex workers in Lagos, Nigeria. J Acquir Immune Defic Syndr 1993, 6:1358-1363.
27. Olaleye O.D., Bernstein L., Ekweozor C.C., Sheng Z., Omilabu S.A., et al. Prevalence of human immunodeficiency virus types 1 and 2 infections in Nigeria. J Infect Dis 1993, 167:710-714.
28. Nnoruka E.N., Ezeoke A.C. Evaluation of syphilis in patients with HIV infection in Nigeria. Trop Med Int Health 2005, 10:58-64.
29. Dada A.J., Ajayi A.O., Diamondstone L., Quinn T.C., Blattner W.A., Biggar R.J. A serosurvey of Haemophilus ducreyi, syphilis, and herpes simplex virus type 2 and their association with human immunodeficiency virus among female sex workers in Lagos, Nigeria. Sex Transm Dis 1998, 25:237-242.
30. Bakare R.A., Oni A.A., Umar U.S., Adewole I.F., Shokunbi W.A., Fayemiwo S.A., et al. Pattern of sexually transmitted diseases among commercial sex workers (CSWs) in Ibadan, Nigeria. Afr J Med Med Sci 2002, 31:243-247.